Study details
Enrolling now
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
Rutgers, The State University of New Jersey
NCT IDNCT05296421ClinicalTrials.gov data as of Apr 2026
Target enrollment
16
Study length
about 4.3 years
Ages
18+
Locations
2 sites in NJ
What this study is about
This trial is testing a treatment that involves using labeled glucose during surgery to understand how pancreatic cancer uses nutrients. The goal is to trace the metabolic activity of pancreatic cancer cells in laboratory experiments, comparing them to normal pancreatic cells.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Undergo Biopsy
- 2.Undergo Therapeutic Conventional Surgery
- 3.Uniformly-labeled [13C]glucose
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
biopsy, surgery